1. Bortezomib-based induction therapy followed by intravenous busulfan–melphalan as conditioning regimen for patients with newly diagnosed multiple myeloma. Issue 2 (February 2015) Authors: Blanes, Margarita; González, José D.; Lahuerta, Juan J.; Ribas, Paz; Lorenzo, Ignacio; Boluda, Blanca; Sanz, Miguel A.; de la Rubia, Javier Journal: Leukemia & lymphoma Issue: Volume 56:Issue 2(2015:Feb.) Page Start: 415 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Clinico‐biological features and outcome of patients with splenic marginal zone lymphoma with histological transformation. (14th September 2021) Authors: Bastidas‐Mora, Gabriela; Beà, Sílvia; Navarro, Alba; Gine, Eva; Costa, Dolors; Delgado, Julio; Baumann, Tycho; Magnano, Laura; Rivas‐Delgado, Alfredo; Villamor, Neus; Colomer, Dolors; Lopez-Guerra, Mónica; Rozman, María; Balagué, Olga; Martínez, Daniel; Baptista, Maria Joao; Escoda, Lourdes; Alco... Journal: British journal of haematology Issue: Volume 196:Number 1(2022) Page Start: 146 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗